Accedi

Bibliografie tematiche / Fluorouracil – Toxicology / Articoli di riviste

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Fluorouracil – Toxicology.

Articoli di riviste sul tema "Fluorouracil – Toxicology"

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 11 febbraio 2022

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Fluorouracil – Toxicology".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

Gintjee, Thomas J., Robert Goodnough, Kai Li, Adina Badea, Kara L. Lynch, Eddie Garcia e Daniel Repplinger. "Real-time comprehensive toxicology testing in the clinical management of accidental pediatric capecitabine ingestion". Journal of Oncology Pharmacy Practice 26, n. 7 (23 febbraio 2020): 1759–61. http://dx.doi.org/10.1177/1078155220906266.

Testo completo

Abstract (sommario):

Introduction Capecitabine is an orally bioavailable prodrug of the chemotherapeutic agent, fluorouracil. Fluorouracil is converted to several active metabolites that induce a cytotoxic effect. Capecitabine toxicity can be life-threatening with a delayed presentation from ingestion. An oral antidote, uridine triacetate, exists but requires the administration of 20 total doses over a course of five days. Case report In this report, we describe a case where timely coordination with a clinical toxicology laboratory was utilized to drive clinical decision making and management. Two children were brought to the emergency department shortly after suspected capecitabine ingestion. Management and outcome Patients were admitted to the hospital and started on uridine triacetate. Real-time comprehensive toxicology testing of the children’s blood was used to rule out capecitabine toxicity and prevent several unnecessary days of hospitalization and doses of antidote. Patients were discharged safely. Discussion Real-time comprehensive toxicology testing on a patient’s blood may be a valuable resource in ruling out or confirming toxic exposure in accidental pediatric ingestion of chemotherapeutic agents like capecitabine when performed in a timely manner.

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Deepa Suruli, Fathima Bushra Sheriff Mirza, Gloria Jemmi Christobel R, Amuthavalli Kottaiswamy, Shila Samuel e Vijayaraghavan Radhakrishnan. "Naringin and 5-fluorouracil suppress inflammatory Cytokines in human skin cancer cell line". International Journal of Research in Pharmaceutical Sciences 12, n. 1 (13 gennaio 2021): 729–33. http://dx.doi.org/10.26452/ijrps.v12i1.4172.

Testo completo

Abstract (sommario):

Naringin is a citrus flavonoid recently studied for anti-inflammatory activity in numerous cancer cells. In this study, the anti-inflammatory properties of naringin along with 5-fluorouracil in human skin cancer cell lines A375 was analyzed. A375 cells were treated with naringin, 5-fluorouracil alone, and combination. MTT assay and cell viability assays was demonstrated to detect the inhibitory effects of naringin or 5-fluorouracil on cell proliferation. mRNA expression of TNFα, IL-6, IL-1β, and NFκB were determined using quantitative RT-PCR. The effect of naringin and 5-fluorouracil combination significantly inhibited the growth and proliferation of the A375 cells in a concentration dependent manner with the IC50 values of naringin (24.75 μM) 5-fluorouracil (2.5 μM). The combination of naringin+5-fluorouracil on A375 cell lines at a concentration of half IC50 values (12µM+1 μM). Naringin and 5-fluorouracil combination also decreased the level of TNFα, IL-6, IL-1β, and NFκB mRNA in the A375 cell line. Naringin and 5-fluorouracil exerted anti-inflammatory effect through the suppression of NF-kB, IL-1β, TNFα, IL-6 in A375 cells. Taken together, our results suggested that treating A375 with naringin and 5-fluorouracil combination may have future applications in treating skin cancers through its anti-inflammatory effect.

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Ohuchida, A., T. Hara, A. Furukawa, S. Sato, M. Katoh, N. Ishihara e T. Shibuya. "Mutagenicity of 5-fluorouracil and its metabolites". Mutation Research/Environmental Mutagenesis and Related Subjects 253, n. 3 (dicembre 1991): 269–70. http://dx.doi.org/10.1016/0165-1161(91)90201-i.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Tan, Biqin, Jing Wang, Mengting Zhao, Yan Hu, Jiajia Wang, Bo Yang, QiaoJun He, Xiao Chun Yang e Qinjie Weng. "TCF7L2 activation is required for myelin regeneration in 5-FU-induced demyelinating mice". Toxicology Research 4, n. 6 (2015): 1597–603. http://dx.doi.org/10.1039/c5tx00110b.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Naren, Gerile, Lu Wang, Xiaolei Zhang, Lijuan Cheng, Shuai Yang, Jiajie Yang, Jiaojiao Guo e Buhe Nashun. "The reversible reproductive toxicity of 5-fluorouracil in mice". Reproductive Toxicology 101 (aprile 2021): 1–8. http://dx.doi.org/10.1016/j.reprotox.2021.02.002.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Polyzos, A., N. Tsavaris, A. Giannopoulos, C. Bacoyiannis, V. Papadimas, N. Kalahanis, G. Karatzas et al. "Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial". Cancer Chemotherapy and Pharmacology 38, n. 3 (giugno 1996): 292–97. http://dx.doi.org/10.1007/s002800050485.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Kopjar, Nevenka, Ivan Milas, Verica Garaj-Vrhovac e Marija Gamulin. "Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients". Human & Experimental Toxicology 26, n. 5 (maggio 2007): 391–99. http://dx.doi.org/10.1177/0960327106076812.

Testo completo

Abstract (sommario):

Spontaneous and chemotherapy-induced sister chromatid exchanges (SCES) and lymphocyte proliferation rate index (PRI) in cultured peripheral lymphocytes were evaluated in 30 patients with diagnosed breast cancer before and after adjuvant chemotherapy and in 30 healthy women with no known familial history of breast cancer. Before chemotherapy, the breast cancer patients had a significantly increased background level of SCE, and lowered PRI as compared with the healthy women. Marked inter-individual variations were observed in both endpoints among the patients. Significantly elevated frequency of SCE and depressed PRI were recorded in blood samples collected after the first cycle of chemotherapy, with high inter-individual variations in the responses to the chemotherapy. FAC (5-fluorouracil, adriamycin and cyclophosphamide) protocol was the most genotoxic of the protocols studied, but also AC (adriamycin, cyclophosphamide) and CMF (cyclophosphamide, methotrexate and 5-fluorouracil) clearly increased SCE. All protocols significantly retarded lymphocyte proliferation in vitro. Our findings indicate that both SCE and PRI may serve as sensitive biomarkers for the routine detection of critical lesions produced by the administration of antineoplastic drugs in the clinical setting, as well as for possible screening of high-risk individuals among patients who have successfully completed chemotherapy. Human & Experimental Toxicology (2007) 26 , 391—399

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Hirata, Kohji, e Toshiharu Horie. "Changes in Intestinal Absorption of 5-Fluorouracil-Treated Rats". Pharmacology & Toxicology 85, n. 3 (settembre 1999): 33–36. http://dx.doi.org/10.1111/j.1600-0773.1999.tb01060.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Werbrouck, Bart F., Walter J. Pauwels e Jan L. De Bleecker. "A case of 5-fluorouracil-induced peripheral neuropathy". Clinical Toxicology 46, n. 3 (gennaio 2008): 264–66. http://dx.doi.org/10.1080/15563650701438763.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Takano, Fumihide, Tomoaki Tanaka, Jiro Aoi, Nobuo Yahagi e Shinji Fushiya. "Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice". Toxicology 201, n. 1-3 (settembre 2004): 133–42. http://dx.doi.org/10.1016/j.tox.2004.04.009.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

11

Lynch, D. W., R. L. Schuler, D. G. Davis e R. D. Hood. "Eye abnormality in drosophila melanogaster exposed to 5-fluorouracil during development". Reproductive Toxicology 6, n. 3 (gennaio 1992): 263–65. http://dx.doi.org/10.1016/0890-6238(92)90182-s.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Hrushesky, William J. M., Rostislav Vyzula e Patricia A. Wood. "Fertility maintenance and 5-fluorouracil timing within the mammalian fertility cycle". Reproductive Toxicology 13, n. 5 (settembre 1999): 413–20. http://dx.doi.org/10.1016/s0890-6238(99)00037-4.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

Tsibiribi, P., C. Bui-Xuan, B. Bui-Xuan, C. Lombard-Bohas, S. Duperret, M. Belkhiria, A. Tabib, G. Maujean, J. Descotes e Q. Timour. "Cardiac lesions induced by 5-fluorouracil in the rabbit". Human & Experimental Toxicology 25, n. 6 (giugno 2006): 305–9. http://dx.doi.org/10.1191/0960327106ht628oa.

Testo completo

Abstract (sommario):

Cardiotoxicity is a rare, but well-recognized complication of treatments with the anti-cancer drug 5-fluorouracil (5FU). The underlying mechanism, however, is not fully elucidated. A spasm of the coronary arteries is often considered to be the leading cause of myocardial ischemia and decreased contractility associated with 5FU. As spasm cannot account for all reported adverse cardiac effects, the present study was undertaken to search for alternative mechanisms. Groups of six rabbits were given either a single intravenous dose of 50 mg/kg 5FU or four intravenous doses of 15 mg/kg 5FU at 7-day intervals. A third group served as control. The heart was removed shortly after death or scheduled sacrifice of the animals, to perform macroscopic and microscopic examinations of the heart and to evidence apoptosis by the TUNEL method. Following a single dose of 50 mg/kg 5FU, all animals rapidly developed a massive hemorrhagic myocardial infarct with spasms of the proximal coronary arteries. Repeated infusions of 15 mg/kg 5FU induced left ventricular hypertrophy, foci of myocardial necrosis, thickening of intra-myocardial arterioles, and disseminated apoptosis in myocardial cells of the epicardium, as well as endothelial cells of the distal coronary arteries. These results indicate that a spasm of the coronary arteries is not the only mechanism of 5FU cardiotoxicity, and that apoptosis of myocardial and endothelial cells can result in inflammatory lesions mimicking toxic myocarditis.

Gli stili APA, Harvard, Vancouver, ISO e altri

14

Zaccaro, L., A. M. Rossi e R. Battolla. "Genotoxic action of 5-fluorouracil (5FU)". Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 181, n. 2 (dicembre 1987): 320. http://dx.doi.org/10.1016/0027-5107(87)90128-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Lee, James J., Jan H. Beumer e Edward Chu. "Therapeutic drug monitoring of 5-fluorouracil". Cancer Chemotherapy and Pharmacology 78, n. 3 (23 maggio 2016): 447–64. http://dx.doi.org/10.1007/s00280-016-3054-2.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Kopelman, Jerome N., e Kunio Miyazawa. "Inadvertent 5-fluorouracil treatment in early pregnancy: A report of three cases". Reproductive Toxicology 4, n. 3 (gennaio 1990): 233–35. http://dx.doi.org/10.1016/0890-6238(90)90064-3.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Stringer, Jessica M., Elyse O. K. Swindells, Nadeen Zerafa, Seng H. Liew e Karla J. Hutt. "Multidose 5-Fluorouracil is Highly Toxic to Growing Ovarian Follicles in Mice". Toxicological Sciences 166, n. 1 (2 agosto 2018): 97–107. http://dx.doi.org/10.1093/toxsci/kfy189.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

Oda, Y., K. Yamamoto, S. Nakamura e I. Oki. "Induction of the SOS responses by 5-fluorouracil in Escherichia coli". Mutation Research/Environmental Mutagenesis and Related Subjects 147, n. 5 (ottobre 1985): 270. http://dx.doi.org/10.1016/0165-1161(85)90106-2.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Ohuchida, A., A. Furukawa, S. Umeno, H. Tamura, N. Horiya, T. Hara, M. Katoh e T. Shibuya. "Effect of multiple treatments with 5-fluorouracil on the micronucleus test". Mutation Research/Environmental Mutagenesis and Related Subjects 252, n. 1 (febbraio 1991): 100–101. http://dx.doi.org/10.1016/0165-1161(91)90296-k.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Hong, C. Y., B. N. Chiang, J. Ku e P. Wu. "Screening the in vitro Sperm-immobilizing Effect of some Anticancer Drugs". Human Toxicology 4, n. 4 (luglio 1985): 461–64. http://dx.doi.org/10.1177/096032718500400412.

Testo completo

Abstract (sommario):

1 The in vitro sperm-immobilizing effect of seven anticancer agents, namely cyclophosphamide, 5-fluorouracil, cytarabine, mitomycin-C, 6-mercaptopurine, doxorubicin and vinblastine were screened with a transmembrane migration method. 2 Only doxorubicin and vinblastine inhibited human sperm motility. 3 Because colchicine, a microtubular inhibitor, had no sperm-immobilizing effect, we suggest that the sperm membrane is the site of action of these two anticancer drugs to inhibit human sperm motility.

Gli stili APA, Harvard, Vancouver, ISO e altri

21

Berg, Stacey L., Frank M. Balis, Cynthia L. McCully, George A. Parker, Robert F. Murphy e David G. Poplack. "Intrathecal 5-fluorouracil in the rhesus monkey". Cancer Chemotherapy and Pharmacology 31, n. 2 (1992): 127–30. http://dx.doi.org/10.1007/bf00685099.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Lerner-Tung, Mary B., Alex Y. C. Chang, Ling S. Ong e Deborah Kreiser. "Pharmacokinetics of intrapericardial administration of 5-fluorouracil". Cancer Chemotherapy and Pharmacology 40, n. 4 (17 giugno 1997): 318–20. http://dx.doi.org/10.1007/s002800050663.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

23

Gaudreault, Jacques, Vanessa Shiu, Ann Bricarello, Brian J. Christian, Christina L. Zuch e Barbara Mounho. "Concomitant Administration of Bevacizumab, Irinotecan, 5-Fluorouracil, and Leucovorin: Nonclinical Safety and Pharmacokinetics". International Journal of Toxicology 24, n. 5 (settembre 2005): 357–63. http://dx.doi.org/10.1080/10915810500209353.

Testo completo

Abstract (sommario):

Bevacizumab (Avastin) is a humanized monoclonal antibody against vascular endothelial growth factor approved for use in combination with 5-fluorouracil (5-FU)-based chemotherapy for first-line treatment of metastatic colorectal cancer. The Saltz regimen (irinotecan/5-FU/leucovorin [LV]) is a first-line treatment for this indication. The objective of this study was to evaluate the safety of bevacizumab when administered concomitantly with the Saltz regimen to cynomolgus monkeys, and to determine if the pharmacokinetics of bevacizumab, irinotecan, SN38 (the active metabolite of irinotecan), or 5-FU were affected by combined administration. Male cynomolgus monkeys were intravenously administered the Saltz regimen (125 mg/m2 irinotecan, 500 mg/m2 5-FU, 20 mg/m2 LV) alone ( n = 4) or concomitantly with 10 mg/kg bevacizumab ( n = 5) on days 1 and 8. All animals survived to euthanasia on day 15. Adverse effects associated with the Saltz regimen included diarrhea and neutropenia. Macroscopically, two animals from each group had small thymus glands that correlated microscopically with lymphoid depletion. Myeloid hypoplasia and/or erythroid hyperplasia was observed in the sternal bone marrow of most animals. These effects were considered to be associated with the Saltz regimen; concomitant bevacizumab administration did not alter the severity of these findings. Irinotecan and 5-FU were observed to be rapidly eliminated ( t1/2 = 1 h and 0.5 h, respectively). Although the number of animals in each group was small and no statistical comparison between groups was performed, bevacizumab did not affect the disposition of either agent. These results indicate that bevacizumab can be safely administered in combination with the Saltz regimen without pharmacokinetic interaction.

Gli stili APA, Harvard, Vancouver, ISO e altri

24

Grafton, Thomas F., Johnny J. Bazare, Deborah K. Hansen e Daniel M. Sheehan. "The in vitro embryotoxicity of 5-fluorouracil in rat embryos". Teratology 36, n. 3 (dicembre 1987): 371–77. http://dx.doi.org/10.1002/tera.1420360314.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Stupans, I., D. A. Richards e M. T. McClure. "Effects of 5-fluorouracil treatment on rat liver microsomal enzymes". Xenobiotica 25, n. 1 (gennaio 1995): 1–8. http://dx.doi.org/10.3109/00498259509061827.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Nakamura, Minoru, Farrel L. Fort e Yasumoto Kikuchi. "Fetal liver micronucleus assay in mice of 5-fluorouracil and related compounds". Mutation Research/Environmental Mutagenesis and Related Subjects 291, n. 1 (febbraio 1993): 29–34. http://dx.doi.org/10.1016/0165-1161(93)90014-q.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Wang, Jun, Wei Liu, Qing Zhao, Qi Qi, Na Lu, Yong Yang, Fei-Fei Nei, Jing-Jing Rong, Qi-Dong You e Qing-Long Guo. "Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma". Toxicology 256, n. 1-2 (febbraio 2009): 135–40. http://dx.doi.org/10.1016/j.tox.2008.11.014.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

28

Robbins, Terry J., Donnell Bowen, Quang Q. Bui e Minh-Tam Tran. "Modulation of high-dose methotrexate toxicity by a non-toxic level of 5-fluorouracil". Toxicology 41, n. 1 (ottobre 1986): 61–73. http://dx.doi.org/10.1016/0300-483x(86)90104-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Gao, Liping, Runyu Ma, Junbo Zhou e Shuzhen Cheng. "Changes of Serum Erythropoietin During Cisplatin- or 5-Fluorouracil-Induced Anemia in Rats". Toxicology Mechanisms and Methods 16, n. 9 (gennaio 2006): 501–6. http://dx.doi.org/10.1080/15376510600751962.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Shuey, Dana L., Robert M. Zucker, Kenneth H. Elstein e John M. Rogers. "Fetal anemia following maternal exposure to 5-fluorouracil in the rat". Teratology 49, n. 4 (aprile 1994): 311–19. http://dx.doi.org/10.1002/tera.1420490411.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Oda, Yoshimitsu. "Induction of SOS responses in Escherichia coli by 5-fluorouracil". Mutation Research/DNA Repair Reports 183, n. 2 (marzo 1987): 103–8. http://dx.doi.org/10.1016/0167-8817(87)90051-4.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Milano, G., A. Thyss, J. Santini, M. Frenay, E. Francois, M. Schneider e F. Demard. "Salivary passage of 5-fluorouracil during continuous infusion". Cancer Chemotherapy and Pharmacology 24, n. 3 (settembre 1989): 197–99. http://dx.doi.org/10.1007/bf00300243.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Eatock, M. M., W. Carlin, D. J. Dunlop, M. Soukop e D. G. Watson. "Bioavailability of subcutaneous 5-fluorouracil: a case report". Cancer Chemotherapy and Pharmacology 38, n. 1 (28 marzo 1996): 110–12. http://dx.doi.org/10.1007/s002800050456.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Li, Yuai, Greg A. Looney, Bruce F. Kimler e A. Hurwitz. "Opiate effects on 5-fluorouracil disposition in mice". Cancer Chemotherapy and Pharmacology 39, n. 3 (2 dicembre 1996): 273–77. http://dx.doi.org/10.1007/s002800050572.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Helsby, N. A., W. Y. Lo, P. Thompson e G. R. Laking. "Do 5-fluorouracil therapies alter CYP2C19 metaboliser status?" Cancer Chemotherapy and Pharmacology 66, n. 2 (17 febbraio 2010): 405–7. http://dx.doi.org/10.1007/s00280-010-1277-1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Thiberville, Luc, Patricia Compagnon, Nicholas Moore, Gerard Bastian, Marie-Odile Richard, Marie-France Hellot, Colette Vincent et al. "Plasma 5-fluorouracil and ?-fluoro-?-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil". Cancer Chemotherapy and Pharmacology 35, n. 1 (1994): 64–70. http://dx.doi.org/10.1007/bf00686286.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Thiberville, L., Patricia Compagnon, Nicholas Moore, Gerard Bastian, Marie-Odile Richard, Marie-France Hellot, Colette Vincent et al. "Plasma 5-fluorouracil and ?-fluoro-?-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil". Cancer Chemotherapy and Pharmacology 35, n. 1 (1 novembre 1994): 64–70. http://dx.doi.org/10.1007/s002800050194.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Khor, S. P., H. Amyx, Stephen T. Davis, Donald Nelson, David P. Baccanari e Thomas Spector. "Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: allometric scaling of animal data, pharmacokinetics and toxicodynamics of 5-fluorouracil in humans". Cancer Chemotherapy and Pharmacology 39, n. 3 (2 dicembre 1996): 233–38. http://dx.doi.org/10.1007/s002800050566.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Elstein, Kenneth H., M. Leonard Mole, R. Woodrow Setzer, Robert M. Zucker, Robert J. Kavlock, John M. Rogers e Christopher Lau. "Nucleoside-Mediated Mitigation of 5-Fluorouracil-Induced Toxicity in Synchronized Murine Erythroleukemic Cells". Toxicology and Applied Pharmacology 146, n. 1 (settembre 1997): 29–39. http://dx.doi.org/10.1006/taap.1997.8208.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

40

Erdem, Burak, Serhat Imamoglu e Nimet Yesim Ercalik. "Needling with 5-fluorouracil for encapsulated blebs after Ahmed glaucoma valve implantation". Cutaneous and Ocular Toxicology 38, n. 4 (12 agosto 2019): 395–400. http://dx.doi.org/10.1080/15569527.2019.1650060.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

Gielen, Marcel, Huairang Ma, Abdeslam Bouhdid, Hassan Dalil, Monique Biesemans e Rudolph Willem. "Di-n-Butyl-, Tri-n-Butyl- and Triphenyltin dl-Terebates: Synthesis, Characterization and In Vitro Antitumour Activity". Metal-Based Drugs 4, n. 4 (1 gennaio 1997): 193–97. http://dx.doi.org/10.1155/mbd.1997.193.

Testo completo

Abstract (sommario):

Di-n-butyltin, tri-n-butyltin and triphenyltin terebates were screened against several human tumour cell lines and found comparably or more active than carboplatin, cis-platin, 5-fluorouracil, methotrexate and doxorubicin, some reference compounds used clinically.

Gli stili APA, Harvard, Vancouver, ISO e altri

42

Kim, Joon Ki, Kyoung Ah Kang, Mei Jing Piao, Yea Seong Ryu, Xia Han, Pattage Madushan Dilhara Jayatissa Fernando, Min Chang Oh et al. "Endoplasmic reticulum stress induces 5-fluorouracil resistance in human colon cancer cells". Environmental Toxicology and Pharmacology 44 (giugno 2016): 128–33. http://dx.doi.org/10.1016/j.etap.2016.05.005.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Hassan, Abdulhameed Abdulmajeed, Marwan Salah Salman e Mazin GH H. AL-Badri. "Pterygium Excision Using Bare Sclera Technique and Adjunctive 5-Fluorouracil Application". Indian Journal of Forensic Medicine & Toxicology 13, n. 4 (2019): 480. http://dx.doi.org/10.5958/0973-9130.2019.00336.0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Weng, Qinjie, Biqin Tan, Jiajia Wang, Jing Wang, Hui Zhou, Jing Shi, QiaoJun He e Bo Yang. "5-Fluorouracil causes severe CNS demyelination by disruption of TCF7L2/HDAC1/HDAC2 complex in adolescent mice". Toxicology 325 (novembre 2014): 144–50. http://dx.doi.org/10.1016/j.tox.2014.08.011.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

Cohen, Philip R. "Chronic cutaneous lupus erythematosus induced by 5-fluorouracil". Expert Review of Clinical Pharmacology 13, n. 8 (17 luglio 2020): 917–18. http://dx.doi.org/10.1080/17512433.2020.1793669.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Strike, David G., William Bonnez e Richard C. Reichman. "Comment: papillomaviruses not in herpes group; fluorouracil in condyloma". Drug Intelligence & Clinical Pharmacy 21, n. 6 (giugno 1987): 549. http://dx.doi.org/10.1177/106002808702100622.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Bolli, E., S. Saccomanno, G. Mondini, C. Aschele, A. Guglielmi, B. Ligas, M. Connio et al. "5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer". Cancer Chemotherapy and Pharmacology 35, n. 4 (1 gennaio 1995): 339–42. http://dx.doi.org/10.1007/s002800050243.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Isard, P. F., e S. G. Rosolen. "5 Fluorouracil Insert Associated with Gonioconjunctival Shunt in Glaucoma Surgery on Cat: Preliminary Results". Journal of Toxicology: Cutaneous and Ocular Toxicology 18, n. 3 (gennaio 1999): 268–69. http://dx.doi.org/10.3109/15569529909044249.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

49

Al-Asmari, AK, AM Al-Zahrani, AQ Khan, HM Al-Shahrani e M. Ali Al Amri. "Taurine ameliorates 5-flourouracil-induced intestinal mucositis, hepatorenal and reproductive organ damage in Wistar rats". Human & Experimental Toxicology 35, n. 1 (27 febbraio 2015): 10–20. http://dx.doi.org/10.1177/0960327115573597.

Testo completo

Abstract (sommario):

5-Fluorouracil is one of the most commonly used anticancer drugs for the treatment of various types of cancer but has potential adverse effects such as intestinal mucositis, renal, hepatic, and reproductive organ toxicity. Attention has been given to approaches to reduce the side effects and improve the therapeutic effectiveness of chemotherapeutic drugs. In this study, we have investigated the protective effect of taurine (Tau) on 5-fluorouracil (5-FU) induced adverse effects in Wistar rats. Animals were divided into four groups with six animals ( n = 6) in each group. Group I received vehicle only and served as control group. Groups II, III, and IV animals were given oral gavage of 5-FU at 50 mg/kg body weight for 4 days. Tau was given to the animals of groups III and IV 30 min prior to 5-FU administration. We observed marked elevation in the myeloperoxidase (MPO) activity after 5-FU administration, which was reversed by Tau pretreatment. Histological observation of liver, kidney, intestine, testis, and prostate revealed that 5-FU administration resulted in anomalies like distortion of normal cellular architecture, infiltration of inflammatory cells, and loss of cellular integrity. These histopathological changes were markedly suppressed by Tau treatment. In conclusion, biochemical and histological findings of this study suggest that Tau has strong preventive potential against complications of anticancer drug 5-FU and hence Tau may play an important role in combinational chemotherapy to enhance the therapeutic efficacy of anticancer drugs.

Gli stili APA, Harvard, Vancouver, ISO e altri

50

Tyagi, Sadhna, Sukh Mahendra Singh, Sujan Gencaslan, W. S. Sheldrick e Udai P. Singh. "Metal–5-Fluorouracil–Histamine Complexes: Solution, Structural, and Antitumour Studies". Metal-Based Drugs 8, n. 6 (1 gennaio 2002): 337–45. http://dx.doi.org/10.1155/mbd.2002.337.

Testo completo

Abstract (sommario):

Solution studies were performed pH-metrically to study the interaction of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) metal ions with 5-fluorouracil (5FU) and histamine (Hm) separately (binary) and in the presence of each other (ternary) at 25±0.1 C° temperature and a constant ionic strength of 0.1 M NaNO3 in aqueous solution. The ternary complexes have been found to be more stable than the corresponding binary complexes as shown by the positive value of Δlog⁡K. The species distribution curves have been obtained using the computer programme BEST. On the basis of species distribution results, efforts were also made to prepare some mixed complexes of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) ions by performing the reaction of their metal nitrates, 5FU and Hm in aqueous ethanol medium at suitable pH. The isolated solid complexes were characterized by different physico-chemical method in order to suggest the possible binding site of the ligands and the structure of the resultant complexes. All these complexes were checked for their antitumour activity by injecting in Dalton's lymphoma (DL) and Sarcoma-180 (S-180) bearing C3H/He mice. The results indicate that some complexes have good antitumour activity both in vivo and in vitro.

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!